Leonard Mazur
Board Member
Citius Pharmaceuticals, Inc. (CTXR)Chairman
Citius Oncology, Inc. (CTOR)Board Member
Citius Oncology, Inc. (CTOR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Leonard Mazur
Leonard Mazur is recorded as Board Member and CEO at Citius Pharmaceuticals, Inc. (CTXR) and CEO, Chairman and Board Member at Citius Oncology, Inc. (CTOR). Leonard Mazur was last confirmed as Board Member at Canton Strategic Holdings, Inc. (CNTN) in a filing dated March 21, 2024. Citius Oncology, Inc. reported in an 8-K filed August 16, 2024 that Leonard Mazur was appointed Chairman, effective August 12, 2024. Citius Oncology, Inc. reported in an 8-K filed August 16, 2024 that Leonard Mazur was appointed Chief Executive Officer, effective August 12, 2024. Citius Oncology, Inc. reported in an 8-K filed August 5, 2024 that Leonard Mazur was appointed Director (Class III). The proxy statement of Citius Pharmaceuticals, Inc. reports total compensation of $3,521,268 for Leonard Mazur in fiscal 2024, including a base salary of $475,000. Disclosed compensation is on record for 3 fiscal years.
“Each of Mr. Myron Holubiak (Class I), Mr. Joel Mayersohn (Class I), Dr. Eugene Holuka (Class II), Mr. Robert Smith (Class II), Ms. Carol Webb (Class II), Mr. Suren Dutia (Class III), Mr. Leonard Mazur (Class III and Chairman) and Mr. Dennis McGrath (Class III) were elected to serve as directors of the Company.”
“Mr. Mazur was appointed to serve as the Company's Chief Executive Officer and Chair of the board of directors”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-12–present
-
Current
2024-01-01–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2021-12-20
Last confirmed by a filing; no departure on record
-
Start not stated–2024-03-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Citius Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Myron Holubiak Chairman, Board Member
- Jaime Bartushak CFO
- Carol Webb Board Member
- Dennis M. McGrath Board Member
- Dennis McGrath Board Member
- Dr. Eugene Holuka Board Member
- Eugene Holuka Board Member
- Joel Mayersohn Board Member
- Jonathan Peri Board Member
- Robert Smith Board Member
Leadership on record at Citius Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Myron Holubiak Chairman
- Jaime Bartushak CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Citius Pharmaceuticals, Inc. (CTXR) | Chief Executive Officer and Executive Chairman | $475,000 | $3,521,268 |
| 2023 | Citius Pharmaceuticals, Inc. (CTXR) | Chief Executive Officer and Executive Chairman | $475,000 | $1,981,113 |
| 2022 | Citius Pharmaceuticals, Inc. (CTXR) | Chief Executive Officer and Executive Chairman | $400,000 | $1,190,056 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.